Related Experiment Video
Updated: Sep 15, 2025
Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
Published on: December 15, 2023
Multidisciplinary multivisceral resections involving the upper digestive tract: a United Kingdom tertiary cancer
Kai Tai Derek Yeung1, Roumaysaa Bouyardan1, Desmond Barton1
1The Royal Marsden Hospital, Fulham Road, Chelsea London, SW3 6JJ, UK.
Purpose:
Multivisceral surgical resections (MVR) are highly specialised procedures involving multidisciplinary surgical teams. MVR can be performed to achieve a complete oncological resection of tumours or to achieve cytoreductive surgery. The aim of the study is to evaluate the peri-operative outcomes of patients undergoing oncological multivisceral or multi-tissue resection which involved concomitant resection of the upper digestive tract/organs (oesophagogastric and hepatopancreatic-biliary).
Methods:
This is a retrospective cohort study of patients treated between May 2019 to May 2023 at the Royal Marsden Hospital, London, United Kingdom. All treatment decisions were ratified at tumour specific multidisciplinary team meetings (MDT).
Results:
A total of twenty-two patients were included in this series. The mean age and BMI were 56.2 years and 26.5 kg/m2 respectively. 86% of patients had ASA Grade II and 91% had WHO performance status of zero or one. 59% of patients underwent some form of tumour specific neoadjuvant treatment prior to surgical resection. The indication for surgery was due to malignancies originating from the upper digestive tract (41%), gynaecological organs (32%) and urinary tract (22%). The majority of cases (68%) involved surgeons from two sperate surgical specialties. 91% of cases involved resection of at least three or more organs or soft tissue groups. The mean critical care length of stay and total length of hospital stay was 2.9 days and 17.8 days respectively. 41% patients required inpatient blood transfusion. Clavien-Dindo Grade II, III and IV complication rates were 68%, 14% and 0% respectively. There were no 30-day re-admissions and no 90-day mortalities. The mean duration of follow up was 23.7 months. At time of analysis, the median overall survival (OS) was 21.0 months.
Conclusions:
Complex MVR can be performed safely with acceptable perioperative outcomes at specialist high-volume centres. To achieve these outcomes patients should be selected carefully on a case-by-case basis with discussion at all respective tumour specific MDTs.
